Navigation Links
Mass. General's Warren Triennial Prize honors discoverers of microRNAs

Two investigators who helped to uncover a previously unsuspected world of tiny RNA molecules will be recognized next month by Massachusetts General Hospital (MGH) with its highest award for research. Victor Ambros, PhD, of the University of Massachusetts Medical School, and Gary Ruvkun, PhD, of the MGH Department of Molecular Biology, are receiving the 2008 Warren Triennial Prize in honor of their discovering that microRNAs play a crucial role in controlling the activity of important genes. The awardees will speak at an October 29 scientific symposium at the hospital's Simches Research Center.

First established in 1871, the Warren Triennial Prize is named for John Collins Warren, a co-founder of the MGH and its first surgeon, who performed the first surgical operation on a patient under ether anesthesia. Over the years, 22 Warren Triennial recipients have also received the Nobel Prize most recently 2004 receipients Craig Mello, PhD, and Andrew Fire, PhD, who subsequently received the 2006 Nobel. This year the celebration has been expanded to include an evening reception and dinner, featuring a talk by Nobel-Prize-winning geneticist Phillip A. Sharp, PhD, of Massachusetts Institute of Technology and an MGH trustee, and the award itself increased to $50,000 for each recipient.

Working in collaboration and independently over the past two decades, Ambros and Ruvkun were the first to find that tiny segments of RNA can turn off other genes by binding to the target genes' RNA. The mechanism they first discovered in the roundworm C. elegans was subsequently shown to apply to animals ranging from flies to mollusks to fish to humans. It now appears that the human genome contains between 500 and 1,000 of these microRNAs, which are involved in a broad range of normal and pathological activities and just beginning to be explored for the diagnosis, prognosis and treatment of diseases. Ambros is a Professor of Molecular Medicine at the University of Massachusetts Medical School and Ruvkun is a Professor of Genetics at Harvard Medical School.


Contact: Sue McGreevey
Massachusetts General Hospital

Related biology news :

1. Mass. General study shows how exercise changes structure and function of heart
2. ETH Zurich professor Ari Helenius awarded Benoist Prize
3. Columbia to award 2007 Horwitz Prize to three generations of teacher-student scientists
4. Gene-targeting pioneer Mario Capecchi shares 2007 Nobel Prize in Medicine
5. Professor Sir Martin Evans wins Nobel Prize for Medicine
6. Gregory Hannon wins 2007 Paul Marks Prize for contributions to understanding and treating cancer
7. Nobel Peace Prize 2007 to intergovernmental panel on climate change
8. NARSAD presents 2007 prizes for outstanding achievement in neuroscience and psychiatric research
9. Neilson member of Nobel Prize-winning panel of scientists
10. Maynard Olson receives $500,000 Gruber Genetics Prize
11. Shigetada Nakanishi receives $500,000 Gruber Neuroscience Prize
Post Your Comments:
(Date:11/9/2015)...  Synaptics Inc. (NASDAQ: SYNA ), the leading ... into the automotive market with a comprehensive and dedicated ... consumer electronics human interface innovation. Synaptics, industry-leading touch controllers, ... automotive industry and will be implemented in numerous locations ... , Japan , and ...
(Date:10/29/2015)... 29, 2015  The J. Craig Venter Institute (JCVI) ... Synthesis and Biosecurity: Lessons Learned and Options for the ... and Human Services guidance for synthetic biology providers has ... --> --> Synthetic biology ... potential to pose unique biosecurity threats. It now is ...
(Date:10/29/2015)... NXTD ) ("NXT-ID" or ... the growing mobile commerce market and creator of ... leading marketplace to discover and buy innovative technology ... on StackSocial for this holiday season.   ... a biometric authentication company focused on the growing ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... and HOLLISTON, Mass. , ... Inc. (Nasdaq: HART ), a biotechnology company developing ... CEO Jim McGorry will present at the ... 1, 2015 at 2:30 p.m. PT. The presentation will ... for 30 days. Management will also be available at ...
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
(Date:11/25/2015)... 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... a fireside chat discussion at the Piper Jaffray 27th ... . The discussion is scheduled for Wednesday, December 2, ... .  A replay will be available for 14 days ... , Julie NormartVP, Corporate Communications and Business Development , ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman ... AngelList early in their initial angel funding process. Now, they are paying it ... to make early stage investments in the microbiome space. In this, they ...
Breaking Biology Technology: